Primogene
Stub active Updated Apr 29, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
About
Primogene is a Leipzig-based biotech startup, founded in 2023 by Dr.-Ing. Reza Mahour, Valerian Grote, and Linda Karger, that uses a proprietary enzymatic platform to produce nature-identical bioactive molecules at industrial scale for nutrition, personal care, and pharmaceutical raw materials 12. Markets include infant nutrition, adult health, pharma, and personal care 1.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-04-29 | Seed | €4.1M | High-Tech Gründerfonds (HTGF) | Technologiegründerfonds Sachsen (TGFS), better ventures, Sächsische Beteiligungsgesellschaft, Golzern Holding, FS Life Science Investment, Dr. Marc Struhalla 12 |
What Investors Say
No independently sourced investor quotes found.
What Founders Say
No independently sourced founder quotes found.
Sources
-
HTGF, “Primogene Raises €4.1 Million to Bring Nature’s Complex Bioactive Molecules to Industrial Scale,” April 2026. https://www.htgf.de/en/primogene-funding/↩↩↩
-
EU-Startups, “Leipzig’s Primogene raises €4.1 million to scale enzymatic biomanufacturing of complex bioactive molecules,” April 29, 2026. https://www.eu-startups.com/2026/04/leipzigs-primogene-raises-e4-1-million-to-scale-enzymatic-biomanufacturing-of-complex-bioactive-molecules/↩↩